Press Releases
-
BioIVT Expands its Biospecimen Portfolio in Support of Neuroscience Research
BioIVT will be available to discuss its newly expanded, comprehensive portfolio of neuro-related disease and TruNormal® biospecimens at Neuroscience 2023.
Oct 26, 2023
-
Catawba Research Announces the Promotion of Andrew Silverman, Ph.D., to CEO
Catawba Research, a leading clinical research organization with a goal to become the world’s most trusted CRO, is announcing changes to its executive leadership team.
Oct 25, 2023
-
Phastar Offers Pro Bono Support to Medicines Development for Global Health
Phastar Offers Pro Bono Support to Medicines Development for Global Health Supporting medicine development for disadvantaged communities
Oct 25, 2023
-
MIB Agents Now Accepting Applications for Annual OutSmarting Osteosarcoma Research Grants
-
Quotient Sciences Announces Major Investment in Sterile Fill/Finish Capacity in Response to Increasing Industry Demand
-
Maximizing Therapeutic Potential: CD Formulation's Versatile Drug Delivery Systems Advance Pharmacokinetics and Pharmacodynamics
-
Elligo and Avallano Launching Patient-First, AI-Powered Clinical Trials Ecosystem
Elligo Health Research®, the largest healthcare-enabling research organization, today announced a partnership with Avallano, a data privacy and healthcare technology company, to launch myTrialsConnectSM, a scalable research community powered by artificial intelligence (AI), that was built to serve patients, providers, sites, and the biopharma industry.
Oct 25, 2023
-
Elemental, Ions and Water (Karl Fischer) Standards Make Analytical Testing More Accurate and Easier
-
Samsung Biologics reports third quarter 2023 financial results
Samsung Biologics (KRX: 207940.KS), the world’s leading contract development and manufacturing organization (CDMO), today announced financial results for the third quarter of fiscal year 2023.
Oct 24, 2023
-
Securing the Integrity of Microneedle Structure Design and Optimization: CD Formulation's Performance Testing Approach
-
Amerigo Scientific Unveils CRISPR/Cas Enzymes to Expand the CRISPR Toolbox
-
Profacgen Updated Its Electrophoretic Mobility Shift Assay (EMSA) Service
-
Creative BioMart Provides a Wide Range of Biomarker Proteins for Research Use
-
Alfa Chemistry Announces the Launch of Innovative IVD Products for Laboratory Use
-
CD BioGlyco Releases One-Stop Services for Glycoprotein-Based Vaccine Development
-
Samsung Biologics and Kurma Partners announce strategic partnership for development and manufacturing of biologics for Kurma’s portfolio companies
-
Creative Biolabs Unveils ADC Services, Igniting Excitement in the Biotech Industry
Creative Biolabs, a prominent provider of groundbreaking biotechnology solutions, proudly announced the expansion of its antibody-drug conjugate (ADC) business with the introduction of novel services.
Oct 22, 2023
-
Creative Enzymes Unveils the Creative SuperCut Series: Redefining Precision in Molecular Biology
-
Creative Enzymes Unveils Advanced Substrate, Inhibitor, and Ligand Screening Services
-
Andelyn Biosciences and Purespring Therapeutics Partner to Manufacture Novel Gene Therapies for Kidney Diseases
Andelyn Biosciences, a gene therapy CDMO, has joined forces with Purespring Therapeutics to accelerate the development of gene therapies for chronic kidney diseases. Purespring is known for its innovative treatments that can slow or halt these diseases. The partnership leverages Andelyn's AAV production expertise and suspension platform under GMP to expedite the clinical advancement of Purespring's therapies. Both organizations share a commitment to improving human health through gene therapies. This collaboration will benefit from Andelyn's advanced GMP manufacturing capabilities in Columbus, Ohio, and is poised to offer hope to patients with kidney diseases.
Oct 19, 2023